Deborah Rathjen, CEO of Bioasis Technologies (BTI.V) talks about the company’s ground-breaking xB3 platform which allows therapeutic drugs to pass through the seemingly impenetrable blood-brain barrier, providing an effective treatment methodology for such neurological disorders as Alzheimer’s disease, Lewy Body Dementia and Parkinson’s. In short, Bioasis’ final frontier solution could very well revolutionize medical science, potentially helping to heal the one billion people suffering from neurological disorders worldwide. Tune in! Equity Guru provides investment information for millennials and madmen. Expert analysis, no punches pulled and no investors left behind. Want to get involved in the public markets, but feel ill-equipped? Already in the markets, but looking for honest source of insight? We can provide the resources that keep you informed, help you build the necessary tools or assist in honing your existing skillset so you can make your investment goals achievable today. Small cap, mid cap, large cap, we cover them all. No the matter the exchange be it, TSX-V, CSE, OTC, NYSE and/or NASDAQ, we have our finger on the pulse. Whether you are a day trader or value investor, we have your back. Social Media: https://twitter.com/equitydotguru https://www.facebook.com/equitydotguru https://www.linkedin.com/company/equity-guru https://www.instagram.com/equity.guru #Investment​ #Trading​ #StockMarket​ #Finance Disclaimer: http://bit.ly/EGdisclaimer